$6.16 Billion Per Drug Approval: Almost Half of Big Pharma Companies Hit Negative R&D Productivity

New study by the St Gallen consortium estimates the cost of one approved drug at $6.16 Billion. 7 of the top 16 pharma companies demonstrated negative R&D productivity.

Related Keywords

Joseph Dimasi ,Oliver Gassman ,Technische Hochschule Ingolstadt ,Alexander Schuhmacher ,Joseph Dimasi At Tufts University ,St Gallen Consortium ,University Of St ,More Research ,Nature Reviews Drug Discovery ,Tufts University ,Drug Discovery Today ,Per New ,Insilico Medicine ,Big Pharma ,Pharmaceutical Industry ,Pharma ,R Ampd Productivity ,Unapproved Drug ,Ai ,